Jianrong Wu

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 6

Top Topics

Combination Therapy

Finite Element Analysis

Top Venues

Pharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Jianrong Wu, Haitao Pan, Chia-Wei Hsu
Bayesian single-arm phase II trial designs with time-to-event endpoints. Pharmaceutical statistics 20 (6) (2021)
Xue Ding, Jianrong Wu
Designing cancer immunotherapy trials with delayed treatment effect using maximin efficiency robust statistics. Pharmaceutical statistics 19 (4) (2020)
Xue Ding, Jianrong Wu
Cancer immunotherapy trial design with long-term survivors. Pharmaceutical statistics 20 (1) (2020)
Jianrong Wu, Jing Wei
Cancer immunotherapy trial design with delayed treatment effect. Pharmaceutical statistics 19 (3) (2019)
Jianrong Wu, Li Chen, Jing Wei, Heidi Weiss, Aman Chauhan
Two-stage phase II survival trial design. Pharmaceutical statistics 19 (3) (2019)
Jianrong Wu, Li Chen, Jing Wei, Heidi Weiss, Rachel W Miller, John L Villano
Phase II trial design with growth modulation index as the primary endpoint. Pharmaceutical statistics 18 (2) (2018)